On-Demand Webinars
-
Navigating Challenges In Immune Cell Therapy Analysis
3/27/2024
During this panel, experts discuss the challenges faced by developers and manufacturers in the immune cell therapy field. These challenges include scalability, regulatory hurdles, and data standardization.
-
MultiTAA-Specific T Cells
3/27/2024
Learn about the MultiTAA T cell therapy approach, and discover how it has enhanced patient outcomes by targeting multiple antigens.
-
Gain Confidence In Your ADCs With Stability Prediction Experiments
3/26/2024
Learn more about the importance of stability experiments early in the development process for antibody drug conjugates (ADCs) with the data collected being used to mitigate stability problems during extended storage or high-concentration use of the ADC.
-
De-Risking Drug Development With Organ-On-A-Chip Contract Research Services
3/25/2024
Delve into Emulate's variety of Organ-on-a-Chip services and tailored study design, supported by data-driven case studies showcasing its collaboration's impact on pharmaceutical decision-making.
-
Dissecting Cancer-Microbiome Interactions With Organoids, Organ-Chips
3/25/2024
Dr. Jens Puschhof from the German Cancer Research Center (DKFZ) explores the potential synergy between organoid biology and Organ-on-a-Chip research, highlighting areas where these two technologies intersect.
-
Accelerating Drug Development For Inflammatory Bowel Disease With Organ-Chips
3/25/2024
Marianne Kanellias unveils how Emulate's Organ-on-a-Chip technology is revolutionizing the field by enabling a more accurate and complex model of IBD pathogenesis.
-
A Regulatory Perspective: How Government Funding Spurs Scientific Innovation
3/25/2024
Review the different ways the United States government supports alternative, innovative approaches for more reliable readouts of toxicity and efficacy.
-
How To Apply Quality By Design Principles To Cell And Gene Therapy Release Testing
3/21/2024
Review how to develop and use QC assays that can facilitate both product and process understanding and control.
-
Detergent-Based Viral Inactivation
3/21/2024
Need to change your viral inactivation method due to environmental concerns? Don’t underestimate how long it will take to change your process.
-
The Increasing Demand For Sterile Filtration Of High Concentration Drugs
3/21/2024
Explore the current trends and challenges with manufacturing high-concentration drug products and an approach to performing extensive filterability trials without a high quantity of expensive product.